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Mycobacteria in the environment
Non Tuberculous Mycobacteria (NTM) are widely distributed in our environment
and man is being constantly exposed to these organisms by various means(l). This
immunologically important contact may be involved in the modulation of immunity to
tuberculosis. Prior sensitization with NTM has beep considered as one of the explanations
for the failure of BCG to provide protection against tuberculosis in the South Indian trial.
Tuberculosis surveys using PPD-B have shown that in this area, prevalence of
sensitization reaches 90%. in persons by age 14(2). Identification of NTM isolates from
sputum samples in this area has shown M.avium-intracellulare and M.scrofulaceum to be
among the important species(3). However. the actual distribution profile of the various
NTM species in the environment of this area is not known.
In order to study this, in the first phase, standardisation experiments were carried
out to choose an optimum method for the isolation of mycobacteria from soil and water
samples(4). In the second phase, utilising the ideal procedure thus evolved. about 150
samples each of soil and water and 75 samples of dust collected from the South Indian
BCG trial area on each of two occasions. once during the summer and once after the
monsoon, were processed and the mycobacteria isolated were identified. Soil and water
samples from a control area in Britain with a very low level of sensitization have also
been included. NTM isolates obtained from sputum samples at the same time from
subjects residing in the same area were also included for the purpose of comparison(5).
The results of the study indicated that the isolates belonging to M.avium complex
(MAC) were predominant in water. dust and sputum samples and isolates belonging to
the M.fortuitum complex were predominant in soil samples. There were no changes in
profile between January and June: however, yield from environmental samples was lower
in June.
Since organisms belonging to MAC include M.avium, M.intracellulare and an
unnamed third specks. and M.fortuitum complex consists of M.fortuitum, M.peregrinum,
M. chelonae, M.abscessus, the unnamed third biovar of M.fortuitum and the MCLO. a
representative number of the isolates of both these groups were subjected to drug and
heavy metal susceptibility studies to see as recorded by others whether susceptibility to
these agents would be of help in comparing environmental and sputum isolates(6).
However, using this procedure, we were unable to distinguish between isolates from the
environment and from sputum.
Molecular characterisation of MAC
Phenotypically identified MAC isolates from different sources were further
chracterised using plasmid profiles(7), identification by 3 specific probes, namely, DT1,
DT6(8) and LiPA(9,10), analysis of lipids using gas chromatography-mass spectrometry
(GC-MS) and analysis of mycolic acid pattern using thin layer chromatography(11). The
results are shown in the Table.
i. Plasmid profile
Plasmid DNA analysis of a total of 62 MAC isolates, 13 each from water and
dust, 16 from soil and 18 from sputum showed that the maximum number of
plasmid-carrying strains were among the non-pigmented strains from water while MAC
strains from sputum yielded few plasmids. These results are in contrast to those reported
for plasmids from MAC strains in earlier studies where they have been reported to be
preferentially found in clinical and aerosol isolates.
ii. Mycolic acid profile:
a. GC-MS : A total of 32 MAC isolates (8 each from water and dust and 10 each from
soil and sputum) were also characterised for their fatty acid composition using W-MS.
Among the dust isolates, 6 were identified as MAC, and 1 each as M.phlei and
M.fortuitum. For soil, 6 were identified as MAC. Of the remaining 4 strains, 3 were
identified as M.fortuitum and 1 as M.xenopi. For sputum, 6 were identified as MAC, 1
each as M.fortuitum and M.xenopi and 2 as M.phlei. For water, 4 were identified as
MAC, 1 each as M.gordonae and M.xenopi, and 2 as M.simiae.
b. TLC : A total of 30 isolates (8 from water, 9 from dust, 11 from soil and 12 from
sputum) were analysed for their mycolic acid pattern using TLC. All the water and dust
isolates tested produced a pattern typical of MAC (type H; d-keto, w-carboxymycolate).
Six isolates from soil and 8 from sputum also produced a type H pattern. Two isolates
from soil and 3 from sputum produced a type D pattern while 3 isolates from soil and 1
from sputum produced a type E pattern.
iii. DNA probe:
a. LiPA: A total of 39 MAC strains (7 from dust, 9 from water, 11 from soil and 12 from
sputum) were tested by the LiPA probe. A total of 16 isolates (3 from water, 5 from
sputum and 8 from soil) were identified as Mycobacterium sp. other than MAC. Of the
remaining 23 strains, none were identified as M.avium or M.intracellulare, 1 but identified
as M.scrofulaceum and 22 as MAC intermediates. Two of the isolates, one each from
soil and sputum were identified as M.malmoense by LiPA and both these isolates were
identified as M.fortuitum by GC-MS.
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b. DT1 and DT2 PCR: A total of 42 isolates were tested by 2 probes for the specific
identification of M.intracellulare (DT1) and M.avium (DT6). Of these, 16 strains tested
positive with DT1 (M.intracellulare) and none with DT6. No strain was identified as
M.avium using these probes.
iv. 16S rRNA and PCR-REA
MAC strains that gave discrepant results. as they were DT1 positive but gave
negative results by the M.intracellulare AccuProbe assay were subjected to a detailed
molecular analysis. These included PCR-restriction enzyme analysis (PRA) of the hsp65
gene and 16S rRNA gene sequencing. The results confirmed the reported heterogeneity
of M.intracellulare as only 32% gave PRA result compatible with published
M.intracellulare profiles while the rest of the isolates were grouped in four previously
unpublished profiles. 16S rRNA gene sequencing showed that only 42% were related to
M.intracellulare, the rest being related to others. In conclusion, by this attempt a
significant number of MAC isolates from South Indian BCG trial area which were not
identified by the AccuProbe assay, (DT1 positive & DT6 negative) were characterised by
PRA or 16S rRNA sequencingt(12).
Thus. these results emphasis the heterogencity of environmental mycobacteria,
particularly of the MAC organisms. However, a tendency for greater agreement of the
results of the various tests for isolates from water and dust was observed while there was
greater discordance for the results of these tests for isolates from soil and sputum.
Immuno modulation studies in animal model
Studies on the modulation of immune response to BCG resulting from prior
exposure to NTM in guinea pig models showed that oral exposure to MAI did not
interfere with subsequent immune response to BCG(13). Prior exposure to NTM by
subcutaneous and intradermal routes also did not interfere with the immune response to
BCG in the early course of challenge infection but it appeared that immuno modulation
could be taking place at the later stages of the infection(14). Some differences were
observed in the immune response and modulation of immune response induced by the
different strains of MAC. And also at 6 weeks after challenge. modulation of protective
response resulting from BCG was observed in the animals sensitized with either MAC
from soil or M.fortuitum from soil (15).
Thus. the results of this study suggest that certain modulation of the protective
immunity due to BCG was probably taking place in animals exposed to NTM first. In
populations of endemic areas of tuberculosis with high prevalence of NTM, prior exposure
to NTM may have similar modulating effect over the immunity due to BCG in the later
course of infection. This may explain, atleast partly, the varying efficacy of BCG seen
in the different vaccination trials (16).
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TABLE
Detailed characterisation using DNA probes (DT1, DT6 and LiPA), GC-MS, TLC
and plasmid profiles of phenotypically identified M.avium complex (MAC)
isolates obtained from different sources in the South Indian BCG trial area.
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I I
NA - NOT AVAILABLE; + - POSITIVE; N - NEGATIVE; ND - NOT DONE; * - CONTAMINATED;
RGM - RAPID GROWING MYCOBACTERIA; MAC - M.avium complex by either GC-MS (pattern typical
for MAC) or LiPA (M.avium, M.intracellulare or MAC intermediates)
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